Australia markets closed

4D Molecular Therapeutics, Inc. (FDMT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
26.380.00 (0.00%)
At close: 04:00PM EDT
26.15 -0.23 (-0.87%)
After hours: 06:14PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-105,198
-100,837
-107,494
-71,317
-56,693
Depreciation & amortisation
3,262
5,749
3,880
3,020
1,443
Stock-based compensation
16,506
19,665
17,121
13,799
4,984
Change in working capital
-2,970
630
-1,336
-15,534
-712
Accounts receivable
791
0
47
1,439
-508
Accounts payable
-1,489
896
-1,638
2,285
43
Other working capital
-101,846
-78,563
-98,221
-78,244
-51,909
Other non-cash items
-
-
-
-
48
Net cash provided by operating activities
-86,307
-75,792
-86,685
-69,134
-50,909
Cash flows from investing activities
Investments in property, plant and equipment
-15,539
-2,771
-11,536
-9,110
-1,000
Purchases of investments
-286,016
-54,802
-153,313
-168,570
0
Sales/maturities of investments
287,993
173,290
147,799
5,000
0
Net cash used for investing activities
-13,562
115,717
-17,050
-172,680
-1,000
Cash flows from financing activities
Common stock issued
148,343
148,344
0
114,296
205,658
Other financing activities
-
-
-468
-
-
Net cash used provided by (used for) financing activities
117,178
156,832
3,085
118,089
278,983
Net change in cash
17,309
196,757
-100,650
-123,725
227,074
Cash at beginning of period
90,989
52,351
153,001
276,726
49,652
Cash at end of period
108,298
249,108
52,351
153,001
276,726
Free cash flow
Operating cash flow
-86,307
-75,792
-86,685
-69,134
-50,909
Capital expenditure
-15,539
-2,771
-11,536
-9,110
-1,000
Free cash flow
-101,846
-78,563
-98,221
-78,244
-51,909